Post-operative nausea and vomiting (PONV)
Conditions
Brief summary
QoR-15swe scores preoperative (baseline) and on POD1
Detailed description
QoR-15swe on POD0, POD2 and POD3, Events of nausea or vomiting at PACU, at the hospital and at home up to POD3., Use of antiemetics at PACU, at the hospital and at home up to POD3., Pain assessments (NRS) at PACU, during hospital stay and at home up to POD3., Time at PACU, Time at hospital until discharge., Events of known side-effect of IMP such as infusion-site reactions, headache, visual disturbances, constipation, diarrhoea and tiredness., Complications from POD0 to POD 30 according to Clavien-Dindo, Themes from qualitative interviews of patient experiences on postoperative recovery using inductive thematic analysis (30-90 days after first visit)
Interventions
Sponsors
Region Vaesternorrland, Umea University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-15swe scores preoperative (baseline) and on POD1 | — |
Secondary
| Measure | Time frame |
|---|---|
| QoR-15swe on POD0, POD2 and POD3, Events of nausea or vomiting at PACU, at the hospital and at home up to POD3., Use of antiemetics at PACU, at the hospital and at home up to POD3., Pain assessments (NRS) at PACU, during hospital stay and at home up to POD3., Time at PACU, Time at hospital until discharge., Events of known side-effect of IMP such as infusion-site reactions, headache, visual disturbances, constipation, diarrhoea and tiredness., Complications from POD0 to POD 30 according to Clavien-Dindo, Themes from qualitative interviews of patient experiences on postoperative recovery using inductive thematic analysis (30-90 days after first visit) | — |
Countries
Sweden
Outcome results
None listed